SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
Clinical trial NCT03546582 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03546582
- Sponsor
- RTOG Foundation, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2027-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.